KYORIN Pharmaceutical Co., Ltd. plays an active role in providing benefit to people's health through revolutionary drug discoveries and the provision of reliable products and services.
Medium-Term Business Plan "HOPE 100 Stage 1"
KYORIN Holdings, Inc. has developed a medium-term business plan for the KYORIN Group. The plan is called "HOPE 100 Stage 1" and covers the period from FY2010 to FY2015. Under the plan, the KYORIN Group will strive to realize its corporate philosophy of cherishing life and benefiting society by contributing to better health.
Drug Discovery Research | Development Research
Creating 1 from 0, then raising 1 to 100
Alliance Strategies
In an effort to enhance the efficiency of new drug development and to increase its sales potential, Kyorin also maintains a positive commitment to forming strategic alliances with leading companies both at home and abroad.
Clinical Development | Drug Fostering Research
Investigating the effectiveness and safety of new drugs, and developing drugs that are easier to use.
Production Technologies
Creating reliable products and managing stable supply.
MR: Medical Representatives
Building relationships of trust and responding to diverse needs.
Healthcare Business
Providing wide-ranging support for healthy lifestyles.
Main Products
Delivering products with a hope for each and every person.
